_id
690f370cccc777a4e85d17ae
Ticker
BMXXY
Name
bioMérieux SA
Exchange
OTCGREY
Address
376 Chemin De l?Orme, Marcy-l'Étoile, France, 69280
Country
USA
Sector
Healthcare
Industry
Diagnostics & Research
Currency
USD
Website
https://www.biomerieux.com
Description
bioMérieux S.A. develops, manufactures, and markets in vitro diagnostic solutions for infectious diseases in France, Europe, Africa, the Middle East, North and South America, the Asia Pacific, and internationally. It operates through Clinical Applications and Industrial Applications segments. The company offers CHROMID RANGE, a chromogen culture media; air, surface, and water monitoring systems; BACT/ALERT VIRTUO, a blood sample culture system; BIOFIRE, a multiplex polymerase chain reaction system (PCR); BIOFIRE SPOTFIRE, a lowplex PCR point-of-care system; VITEK MS, a mass spectrometry system; VITEK 2, an automated identification and antimicrobial susceptibility testing (AST) system; API RANGE standardized ID strips; VITEK REVEAL, a rapid AST system; ETEST, a gradient method on culture media; BIOMERIEUX EPISEQ CS, a whole genome sequencing solution for epidemiologic monitoring; VIDAS, a specific marker of severe bacterial infections/sepsis; and Biomérieux vision suite, a software that provides information to support diagnosis and clinical decision making. It also provides culture media and associated instruments; ARGENE that provides PCR tests for diagnosing viral respiratory diseases; EMAG system and NUCLISENS extraction reagents for DNA and RNA extraction; GENE-UP and VERIFLOW for detection of microorganisms for the food industry; ETEST for manual measurement of minimum inhibitory concentration of an antibiotic; API and RAPIDEC CARBA NP for identification of bacteria and manual antimicrobial susceptibility testing; BIOBALL for quantitative microbiological quality control; CHEMUNEX, a microbiology instrument; ENDONEXT for detection of endotoxins; TEMPO for fluorescence counting of bacteria; and Hybiome, a CLIA technology, as well as lab consultancy service and training modules. The company was formerly known as B-D Mérieux. The company was founded in 1963 and is headquartered in Marcy-l'Étoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.
Last Close
14.55
Volume
100
Current Price
14.55
Change
0.17
Last Updated
2026-01-20T16:48:06.314Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
17664210944
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2022-06-30
Revenue
-
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
-
Operating Income
-
Interest Expense
-
Pretax Income
-
Net Income
-
Eps
-
Dividends Per Share
50600000
Shares Outstanding
1180672050
Income Tax Expense
32600000
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
-
Cash
-
Short Term Investments
-
Receivables
825700000
Inventories
708500000
Total Current Assets
2065900000
Property Plant Equipment
1314400000
Total Assets
-
Payables
243400000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
1020700000
Equity
-
Bs_currency_symbol
USD
Depreciation
50200000
Change In Working Capital
-
Cash From Operations
75450000
Capital Expenditures
76400000
Cash From Investing
-176150000
Cash From Financing
-63900000
Net Change In Cash
-136950000
Cf_currency_symbol
USD
PE
39.3243
PB
-
ROE
-
ROA
-
FCF
-950000
Fcf Percent
-
Piotroski FScore
1
Health Score
46
Deep Value Investing Score
1
Defensive Investing Score
5
Dividend Investing Score
1.5
Economic Moat Investing Score
1.5
Garp Investing Score
0
Growth Investing Score
0
Momentum Investing Score
2.5
Net Net Investing Score
0
Quality Investing Score
0.5
Value Investing Score
2.5
Quarters > 0 > quarter
2022-06-30
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
-
Quarters > 0 > income Statement > operating Income
-
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-
Quarters > 0 > income Statement > net Income
-
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
50600000
Quarters > 0 > income Statement > shares Outstanding
-
Quarters > 0 > income Statement > income Tax Expense
32600000
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
-
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
825700000
Quarters > 0 > balance Sheet > inventories
708500000
Quarters > 0 > balance Sheet > total Current Assets
2065900000
Quarters > 0 > balance Sheet > property Plant Equipment
1314400000
Quarters > 0 > balance Sheet > total Assets
-
Quarters > 0 > balance Sheet > payables
243400000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
1020700000
Quarters > 0 > balance Sheet > equity
-
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
114000000
Quarters > 0 > cash Flow > depreciation
50200000
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
75450000
Quarters > 0 > cash Flow > capital Expenditures
76400000
Quarters > 0 > cash Flow > cash From Investing
-176150000
Quarters > 0 > cash Flow > cash From Financing
-63900000
Quarters > 0 > cash Flow > net Change In Cash
-136950000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
-
Quarters > 0 > ratios > ROA
-
Quarters > 0 > ratios > FCF
-950000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
46
Quarters > 1 > quarter
2022-03-31
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
-
Quarters > 1 > income Statement > operating Income
-
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-
Quarters > 1 > income Statement > net Income
-
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
50600000
Quarters > 1 > income Statement > shares Outstanding
-
Quarters > 1 > income Statement > income Tax Expense
32600000
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
-
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
825700000
Quarters > 1 > balance Sheet > inventories
708500000
Quarters > 1 > balance Sheet > total Current Assets
2065900000
Quarters > 1 > balance Sheet > property Plant Equipment
1314400000
Quarters > 1 > balance Sheet > total Assets
-
Quarters > 1 > balance Sheet > payables
243400000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1020700000
Quarters > 1 > balance Sheet > equity
-
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
114000000
Quarters > 1 > cash Flow > depreciation
50200000
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
75450000
Quarters > 1 > cash Flow > capital Expenditures
76400000
Quarters > 1 > cash Flow > cash From Investing
-176150000
Quarters > 1 > cash Flow > cash From Financing
-63900000
Quarters > 1 > cash Flow > net Change In Cash
-136950000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
-
Quarters > 1 > ratios > ROA
-
Quarters > 1 > ratios > FCF
-950000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
46
Quarters > 2 > quarter
2021-12-31
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
-
Quarters > 2 > income Statement > operating Income
-
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-
Quarters > 2 > income Statement > net Income
-
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
50600000
Quarters > 2 > income Statement > shares Outstanding
-
Quarters > 2 > income Statement > income Tax Expense
46550000
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
-
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
701400000
Quarters > 2 > balance Sheet > inventories
634600000
Quarters > 2 > balance Sheet > total Current Assets
2207100000
Quarters > 2 > balance Sheet > property Plant Equipment
1224800000
Quarters > 2 > balance Sheet > total Assets
-
Quarters > 2 > balance Sheet > payables
239500000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
955800000
Quarters > 2 > balance Sheet > equity
-
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
162000000
Quarters > 2 > cash Flow > depreciation
66800000
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
262650000
Quarters > 2 > cash Flow > capital Expenditures
73300000
Quarters > 2 > cash Flow > cash From Investing
-81950000
Quarters > 2 > cash Flow > cash From Financing
-26600000
Quarters > 2 > cash Flow > net Change In Cash
167300000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
-
Quarters > 2 > ratios > ROA
-
Quarters > 2 > ratios > FCF
189350000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
46
Quarters > 3 > quarter
2021-09-30
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
-
Quarters > 3 > income Statement > operating Income
-
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-
Quarters > 3 > income Statement > net Income
-
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
50600000
Quarters > 3 > income Statement > shares Outstanding
-
Quarters > 3 > income Statement > income Tax Expense
46550000
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
-
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
701400000
Quarters > 3 > balance Sheet > inventories
634600000
Quarters > 3 > balance Sheet > total Current Assets
2207100000
Quarters > 3 > balance Sheet > property Plant Equipment
1224800000
Quarters > 3 > balance Sheet > total Assets
-
Quarters > 3 > balance Sheet > payables
239500000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
955800000
Quarters > 3 > balance Sheet > equity
-
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
162000000
Quarters > 3 > cash Flow > depreciation
66800000
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
262650000
Quarters > 3 > cash Flow > capital Expenditures
73300000
Quarters > 3 > cash Flow > cash From Investing
-81950000
Quarters > 3 > cash Flow > cash From Financing
-26600000
Quarters > 3 > cash Flow > net Change In Cash
167300000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
-
Quarters > 3 > ratios > ROA
-
Quarters > 3 > ratios > FCF
189350000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
46
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
3979900000
Annuals > 0 > income Statement > cost Of Revenue
1764600000
Annuals > 0 > income Statement > gross Profit
2215300000
Annuals > 0 > income Statement > operating Expenses
3342000000
Annuals > 0 > income Statement > operating Income
637900000
Annuals > 0 > income Statement > interest Expense
16000000
Annuals > 0 > income Statement > pretax Income
579300000
Annuals > 0 > income Statement > net Income
432200000
Annuals > 0 > income Statement > eps
3.664906087163101
Annuals > 0 > income Statement > dividends Per Share
100200000
Annuals > 0 > income Statement > shares Outstanding
117929352
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
16.02804090555039
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
EUR
Annuals > 0 > balance Sheet > cash
449800000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
792300000
Annuals > 0 > balance Sheet > inventories
1037300000
Annuals > 0 > balance Sheet > total Current Assets
2501100000
Annuals > 0 > balance Sheet > property Plant Equipment
1695700000
Annuals > 0 > balance Sheet > total Assets
5770000000
Annuals > 0 > balance Sheet > payables
272400000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
207100000
Annuals > 0 > balance Sheet > total Liabilities
1559000000
Annuals > 0 > balance Sheet > equity
4204900000
Annuals > 0 > balance Sheet > currency_symbol
EUR
Annuals > 0 > cash Flow > net Income
432200000
Annuals > 0 > cash Flow > depreciation
302200000
Annuals > 0 > cash Flow > change In Working Capital
-51000000
Annuals > 0 > cash Flow > cash From Operations
667300000
Annuals > 0 > cash Flow > capital Expenditures
345800000
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
-
Annuals > 0 > cash Flow > net Change In Cash
94800000
Annuals > 0 > cash Flow > currency_symbol
EUR
Annuals > 0 > ratios > PE
3.664906087163101
Annuals > 0 > ratios > PB
0.4080648937192323
Annuals > 0 > ratios > ROE
10.278484625080264
Annuals > 0 > ratios > ROA
7.49046793760832
Annuals > 0 > ratios > FCF
321500000
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
0.08078092414382271
Annuals > 0 > health Score
72
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
3674600000
Annuals > 1 > income Statement > cost Of Revenue
1617400000
Annuals > 1 > income Statement > gross Profit
2057200000
Annuals > 1 > income Statement > operating Expenses
3105700000
Annuals > 1 > income Statement > operating Income
568900000
Annuals > 1 > income Statement > interest Expense
15800000
Annuals > 1 > income Statement > pretax Income
437500000
Annuals > 1 > income Statement > net Income
357600000
Annuals > 1 > income Statement > eps
3.0264073847996253
Annuals > 1 > income Statement > dividends Per Share
100200000
Annuals > 1 > income Statement > shares Outstanding
118159902
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
15.48195721983345
Annuals > 1 > income Statement > total Other Income Expense Net
-
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
352400000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
728600000
Annuals > 1 > balance Sheet > inventories
908500000
Annuals > 1 > balance Sheet > total Current Assets
2205100000
Annuals > 1 > balance Sheet > property Plant Equipment
1506200000
Annuals > 1 > balance Sheet > total Assets
5259200000
Annuals > 1 > balance Sheet > payables
265100000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
234100000
Annuals > 1 > balance Sheet > total Liabilities
1507000000
Annuals > 1 > balance Sheet > equity
3752200000
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
358000000
Annuals > 1 > cash Flow > depreciation
258900000
Annuals > 1 > cash Flow > change In Working Capital
-203300000
Annuals > 1 > cash Flow > cash From Operations
445400000
Annuals > 1 > cash Flow > capital Expenditures
338300000
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
-
Annuals > 1 > cash Flow > net Change In Cash
-165700000
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
3.0264073847996253
Annuals > 1 > ratios > PB
0.4581916140131123
Annuals > 1 > ratios > ROE
9.5304088268216
Annuals > 1 > ratios > ROA
6.799513233951932
Annuals > 1 > ratios > FCF
107100000
Annuals > 1 > ratios > Piotroski FScore
4
Annuals > 1 > ratios > fcf Percent
0.029146029499809503
Annuals > 1 > health Score
65
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
3589000000
Annuals > 2 > income Statement > cost Of Revenue
1580400000
Annuals > 2 > income Statement > gross Profit
2008600000
Annuals > 2 > income Statement > operating Expenses
2963300000
Annuals > 2 > income Statement > operating Income
625700000
Annuals > 2 > income Statement > interest Expense
4100000
Annuals > 2 > income Statement > pretax Income
580500000
Annuals > 2 > income Statement > net Income
452400000
Annuals > 2 > income Statement > eps
3.835648856216124
Annuals > 2 > income Statement > dividends Per Share
101200000
Annuals > 2 > income Statement > shares Outstanding
117946146
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
17.433825578155478
Annuals > 2 > income Statement > total Other Income Expense Net
-
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
552600000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
740100000
Annuals > 2 > balance Sheet > inventories
737200000
Annuals > 2 > balance Sheet > total Current Assets
2216700000
Annuals > 2 > balance Sheet > property Plant Equipment
1369900000
Annuals > 2 > balance Sheet > total Assets
5186600000
Annuals > 2 > balance Sheet > payables
269400000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
224800000
Annuals > 2 > balance Sheet > total Liabilities
1543700000
Annuals > 2 > balance Sheet > equity
3604200000
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
452400000
Annuals > 2 > cash Flow > depreciation
248000000
Annuals > 2 > cash Flow > change In Working Capital
-155900000
Annuals > 2 > cash Flow > cash From Operations
475100000
Annuals > 2 > cash Flow > capital Expenditures
286700000
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
-
Annuals > 2 > cash Flow > net Change In Cash
-297200000
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
3.835648856216124
Annuals > 2 > ratios > PB
0.47614350599300814
Annuals > 2 > ratios > ROE
12.552022640253039
Annuals > 2 > ratios > ROA
8.72247715266263
Annuals > 2 > ratios > FCF
188400000
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
0.05249373084424631
Annuals > 2 > health Score
72
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
3376200000
Annuals > 3 > income Statement > cost Of Revenue
1375400000
Annuals > 3 > income Statement > gross Profit
2000800000
Annuals > 3 > income Statement > operating Expenses
2532200000
Annuals > 3 > income Statement > operating Income
844000000
Annuals > 3 > income Statement > interest Expense
9100000
Annuals > 3 > income Statement > pretax Income
774500000
Annuals > 3 > income Statement > net Income
601100000
Annuals > 3 > income Statement > eps
5.08191809326095
Annuals > 3 > income Statement > dividends Per Share
73100000
Annuals > 3 > income Statement > shares Outstanding
118282111
Annuals > 3 > income Statement > income Tax Expense
175600000
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
24.99851904508027
Annuals > 3 > income Statement > total Other Income Expense Net
-
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
803500000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
590600000
Annuals > 3 > balance Sheet > inventories
634600000
Annuals > 3 > balance Sheet > total Current Assets
2207100000
Annuals > 3 > balance Sheet > property Plant Equipment
1225000000
Annuals > 3 > balance Sheet > total Assets
4605000000
Annuals > 3 > balance Sheet > payables
239500000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
265200000
Annuals > 3 > balance Sheet > total Liabilities
1441400000
Annuals > 3 > balance Sheet > equity
3112200000
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
601100000
Annuals > 3 > cash Flow > depreciation
230900000
Annuals > 3 > cash Flow > change In Working Capital
-22800000
Annuals > 3 > cash Flow > cash From Operations
811100000
Annuals > 3 > cash Flow > capital Expenditures
290100000
Annuals > 3 > cash Flow > cash From Investing
-307300000
Annuals > 3 > cash Flow > cash From Financing
-127000000
Annuals > 3 > cash Flow > net Change In Cash
416000000
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
5.08191809326095
Annuals > 3 > ratios > PB
0.5529865416907654
Annuals > 3 > ratios > ROE
19.31431141957458
Annuals > 3 > ratios > ROA
13.053203040173726
Annuals > 3 > ratios > FCF
521000000
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
0.15431550263609975
Annuals > 3 > health Score
88
Valuation > metrics > PE
39.3243
Valuation > final Score
32.81084
Valuation > verdict
57.3% Overvalued
Profitability > final Score
50
Profitability > verdict
Weak
Risk > final Score
50
Risk > verdict
High
Liquidity > metrics > Current Ratio
8.487674609695974
Liquidity > metrics > Quick Ratio
5.57682826622843
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
50
Prev Profitabilities > 1
50
Prev Profitabilities > 2
50
Prev Risks > 0
50
Prev Risks > 1
50
Prev Risks > 2
50
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:30:28.937Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-05
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
bioMérieux S.A. develops, manufactures, and markets in vitro diagnostic solutions for infectious diseases in France, Europe, Africa, the Middle East, North and South America, the Asia Pacific, and internationally. It operates through Clinical Applications and Industrial Applications segments. The company offers CHROMID RANGE, a chromogen culture media; air, surface, and water monitoring systems; BACT/ALERT VIRTUO, a blood sample culture system; BIOFIRE, a multiplex polymerase chain reaction system (PCR); BIOFIRE SPOTFIRE, a lowplex PCR point-of-care system; VITEK MS, a mass spectrometry system; VITEK 2, an automated identification and antimicrobial susceptibility testing (AST) system; API RANGE standardized ID strips; VITEK REVEAL, a rapid AST system; ETEST, a gradient method on culture media; BIOMERIEUX EPISEQ CS, a whole genome sequencing solution for epidemiologic monitoring; VIDAS, a specific marker of severe bacterial infections/sepsis; and Biomérieux vision suite, a software that provides information to support diagnosis and clinical decision making. It also provides culture media and associated instruments; ARGENE that provides PCR tests for diagnosing viral respiratory diseases; EMAG system and NUCLISENS extraction reagents for DNA and RNA extraction; GENE-UP and VERIFLOW for detection of microorganisms for the food industry; ETEST for manual measurement of minimum inhibitory concentration of an antibiotic; API and RAPIDEC CARBA NP for identification of bacteria and manual antimicrobial susceptibility testing; BIOBALL for quantitative microbiological quality control; CHEMUNEX, a microbiology instrument; ENDONEXT for detection of endotoxins; TEMPO for fluorescence counting of bacteria; and Hybiome, a CLIA technology, as well as lab consultancy service and training modules. The company was formerly known as B-D Mérieux. The company was founded in 1963 and is headquartered in Marcy-l'Étoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2022-06-30)
Health Score
Price to Earnings Ratio (P/E)
-
Low
Low ≥ 50
High ≤ 10
* Institutions hold a combined 0.00% of the total shares of bioMérieux SA
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
—
EPS Actual
—
EPS Estimate
—
EPS Difference
—
Surprise Percent
undefined%
(Last Updated 2022-06-30)
(Last Updated 2022-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2022-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2022-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.